文献速递主动脉疾病

心肺运动试验评估体能差的患者行EVAR可能获得生存优势

Endovascular Aneurysm Repair May Provide a Survival Advantage in Patients Deemed Physiologically Ineligible for Open Abdominal Aortic Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2019-08-05

EVAR组1、3、5年全因生存率分别为97%、92%、81%,非手术组为72%、48%、24%(HR=5.13,P=0.004);动脉瘤特异生存率EVAR组为97%、94%、94%,非手术组为90%、69%、39%(HR=7.48,P=0.02)。结论提示在此小样本回顾性队列中,EVAR可能为CPET评估体能差的患者提供生存优势。

要点

  • CPET无氧阈<11 mL/min/kg提示体能差,此类患者行EVAR的5年全因生存率81% vs 非手术24%。
  • EVAR组5年动脉瘤特异生存率94%,非手术组39%,HR=7.48(P=0.02)。
  • 结果来自小样本单中心回顾性非随机队列,需随机研究验证。

核心结论

  • 在CPET评估体能差的患者中,EVAR可能较非手术管理提供全因和动脉瘤特异生存优势。
  • 该结论来自小样本、回顾性、单中心、非随机队列,需现代EVAR随机研究验证。

研究设计与样本

  • 回顾性分析前瞻性维护的CPET数据库,纳入因择期肾下腹主动脉瘤修复而接受CPET的患者。

主要发现

  • EVAR组1、3、5年全因生存率分别为97%、92%、81%,非手术组分别为72%、48%、24%。
  • EVAR组1、3、5年动脉瘤特异生存率分别为97%、94%、94%,非手术组分别为90%、69%、39%。

关键数值与推荐

  • 无氧阈<11 mL/min/kg用于指示体能差。
  • EVAR组5年全因生存率81%,非手术组24%,HR=5.13(1.67-15.82),P=0.004。
  • EVAR组5年动脉瘤特异生存率94%,非手术组39%,HR=7.48(1.37-40.82),P=0.02。

临床怎么用

  • 对拟行择期肾下腹主动脉瘤修复的患者,CPET无氧阈<11 mL/min/kg可识别体能差者。
  • 在此类体能差患者中,EVAR可能较非手术管理改善生存,但证据级别受回顾性设计限制。

局限性

  • 小样本、回顾性、单中心、非随机队列。
  • 作者指出需现代EVAR的随机研究验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiopulmonary exercise testing (CPET) provides an objective assessment of functional capacity and fitness. It can be used to guide decision making prior to major vascular surgery. The EVAR-2 trial suggested that endovascular aneurysm repair (EVAR) in patients unfit for open repair failed to provide a significant survival advantage over nonsurgical management. The aim of this study is to assess contemporary survival differences between patients with poor CPET measures who underwent EVAR or were not offered surgical intervention. METHODS: A prospectively maintained database of CPET results of patients considered for elective infrarenal aortic aneurysm repair were interrogated. Anaerobic threshold (AT) of <11 mL/min/kg was used to indicate poor physical fitness. Hospital electronic records were then reviewed for perioperative, reintervention, and long-term outcomes. RESULTS: Between November 2007 and October 2017, 532 aortic aneurysm repairs were undertaken, of which 376 underwent preoperative CPET. Seventy patients were identified as having an AT <11 mL/min/kg. Thirty-seven patients underwent EVAR and 33 were managed nonsurgically. All-cause survival at 1, 3, and 5 years for those patients who underwent EVAR was 97%, 92%, and 81%, respectively. For those not offered surgical intervention survival at the same points was 72%, 48%, and 24% [hazard ratio, HR = 5.13 (1.67-15.82), P = 0.004]. Aneurysm-specific survival at 1, 3, and 5 years for those patients who underwent EVAR was 97%, 94%, and 94%, respectively. Survival at the same time points for those not offered surgical intervention was 90%, 69%, and 39%, respectively [HR = 7.48 (1.37-40.82), P = 0.02]. CONCLUSIONS: In this small, retrospective, single-center, nonrandomized cohort, EVAR may provide a survival advantage in patients with poor physical fitness identified via CPET. Randomized studies with current generation EVAR are required to validate the results shown here.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Fisher O, Gates Z, Parkes E, et al. Endovascular Aneurysm Repair May Provide a Survival Advantage in Patients Deemed Physiologically Ineligible for Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2019. PMID: 31394243. doi:10.1016/j.avsg.2019.05.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。